Challa Kumar is currently the Director of Nanofabrication & Nanomaterials at the Center for Advanced Microstructures and Devicees (CAMD), Baton Rouge, USA. He is also the President and CEO of Magnano Technologies, a company established to commercialize nanomaterials for applications in life sciences. His research interests are in developing novel synthetic methods, including those based on microfluidic reactors, for multifunctional nanomaterials. He has also been involved in the development of innovative therapeutic & diagnostic tools based on nanotechnology. He has eight years of industrial R&D experience working for Imperial Chemical Industries and United Breweries. He is the founding Editor-in-Chief of the Journal of Biomedical Nanotechnology, published by American Scientific Publishers and Series editor for the ten-volume book series, Nanotechnologies for the Life Sciences (NtLS), published by Wiley-VCH.